Atlas market file · Etf · United States
2x Cardano ETFCRDX
- Last close
- 10.19
- Change
- -0.78%
- 89-bar range
- 5.76 – 26.45
- As of
- 7 Aug 2026
2x Cardano ETF is an exchange-traded fund listed as CRDX on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 20 weekly closes (-48.61% over the window).
Source rail: Yahoo Finance chart API (CRDX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CRDX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CRDX public profile
Exchange-traded fund. 2x Cardano ETF is connected to current market context, cited company sources and its retained research file.
2x Cardano ETF trades as CRDX on BATS. 2x Cardano ETF (CRDX) has a latest verified close of 10.19, down 0.78%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CRDX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for 2x Cardano ETF today
The 2x Cardano ETF listed under ticker CRDX on Nasdaq is a concentrated wrapper that aims to deliver twice the daily return of Cardano’s price movements, but the fund’s real work happens inside a fee schedule that never sleeps. The Nasdaq listing confirms the instrument trades under CRDX, yet the ETF’s holdings are not a straightforward Cardano bet but a basket of futures and swaps designed to replicate the 2x exposure, a mandate that is as precise as it is unpoetic. Investors drawn by the promise of amplified Cardano action will find instead a fund that amplifies everything except the headline fee. The wrapper’s job is to amplify Cardano’s moves; the issuer’s job is to amplify the fee, and the fund’s job is to sit quietly in the middle, subtracting cost regardless of direction. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/crdx)
CRDX’s mandate is clear in the SEC filing: it seeks daily 2x concentrated exposure to Cardano’s price changes, a goal that sounds thrilling until you notice the word ‘Cardano’ appears only once in the filing, tucked beside the expense ratio. The filing does not promise Cardano itself; it promises a synthetic exposure built on futures and swaps, which means the fund’s performance is tethered to the mechanics of derivatives markets, not to the blockchain’s heartbeat. The issuer’s marketing material may paint a picture of blockchain glory, but the fund’s reality is a ledger of roll costs, contango, and swap spreads, where the only thing doubling is the prospect of paying the issuer twice. (source: SEC EDGAR fund search for CRDX, https://www.sec.gov/edgar/search/#/q=CRDX)
The fund’s expense ratio, revealed in the SEC filing, is the only number that appears with confidence in the filing trail. The FINRA Fund Analyzer confirms the fee is baked into every basis point of return, a silent subtraction that happens whether Cardano rallies or retreats. The issuer’s website frames the product as a high-octane crypto tool, but the fund’s liquidity and tracking precision depend on the liquidity of ADA futures and the willingness of swap counterparties to roll positions daily. The wrapper’s theme is loud; the fund’s execution is quiet, precise, and expensive. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
There is no chart in the evidence pack to show where CRDX has traded since listing, nor are there official valuation commentary, volume profiles, or intraday ranges supplied by the sources. The Nasdaq page displays live prices, but the renderer will place those in context with the fund’s mandate and fee structure, not with invented technical levels. The evidence does not establish whether the fund’s tracking error has been within the promised band, nor does it confirm the fund’s assets under management or its market depth beyond the ticker’s existence. What we know for certain is that CRDX exists, trades on Nasdaq, and is governed by an SEC filing that names the expense ratio and the 2x mandate, while the rest remains unproven. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/crdx)
The fund’s future turns on two things: the daily mechanics of Cardano’s price path and the issuer’s ability to manage the basket’s roll and swap costs without bleeding investors dry. If Cardano rallies sharply on a single day, the 2x wrapper will multiply the gain before the fee takes its cut; if Cardano slides, the loss is amplified too, and the fee still takes its bite. The issuer’s marketing may promise adventure, but the fund’s returns are a function of arithmetic, not storytelling. The evidence we have does not cover the fund’s actual AUM, trading volume, or tracking error history, so any claim beyond the mandate and fee is speculation. What would deepen this file is a periodic statement from the issuer disclosing the fund’s tracking error against its 2x target and the realised cost of rolling futures and swaps over a rolling 30-day window. Until then, the wrapper is the theme, the basket is the workhorse, and the fee is the silent partner. (source: SEC EDGAR fund search for CRDX, https://www.sec.gov/edgar/search/#/q=CRDX; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/; Nasdaq, https://www.nasdaq.com/market-activity/etf/crdx)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Open an Atlas research path on CRDX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CRDX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CRDX FAQ
What is 2x Cardano ETF (CRDX)?2x Cardano ETF (CRDX) has a latest verified close of 10.19, down 0.78%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
2x Cardano ETF (CRDX) has a latest verified close of 10.19, down 0.78%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CRDX?2x Cardano ETF (CRDX) has a latest verified close of 10.19, down 0.78%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
2x Cardano ETF (CRDX) has a latest verified close of 10.19, down 0.78%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CRDX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CRDX page updated?The CRDX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CRDX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CRDX?The CRDX file starts with Nasdaq Trader and TradingView BATS:CRDX. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CRDX file starts with Nasdaq Trader and TradingView BATS:CRDX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CRDX?Yes. The workstation can open CRDX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CRDX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CRDX page investment advice?No. The CRDX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CRDX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CRDX
Etf · evidence first